306 related articles for article (PubMed ID: 26837851)
1. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
Liebscher C; Wittmann A; Gechter J; Schlagenhauf F; Lueken U; Plag J; Straube B; Pfleiderer B; Fehm L; Gerlach AL; Kircher T; Fydrich T; Deckert J; Wittchen HU; Heinz A; Arolt V; Ströhle A
Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
[TBL] [Abstract][Full Text] [Related]
2. Patients' characteristics and their influence on course of fear during agoraphobic symptom provocation: may SS(N)RI treatment compensate unfavorable individual preconditions?
Plag J; Petzold MB; Gechter J; Liebscher C; Ströhle A
Nord J Psychiatry; 2018 Jul; 72(5):325-335. PubMed ID: 29644923
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
4. Influence of personality disorder on the treatment of panic disorder--comparison study.
Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
[TBL] [Abstract][Full Text] [Related]
5. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
6. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
[TBL] [Abstract][Full Text] [Related]
7. Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia.
Lueken U; Straube B; Wittchen HU; Konrad C; Ströhle A; Wittmann A; Pfleiderer B; Arolt V; Kircher T; Deckert J; Reif A
J Neural Transm (Vienna); 2015 Jan; 122(1):135-44. PubMed ID: 25223844
[TBL] [Abstract][Full Text] [Related]
8. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
[TBL] [Abstract][Full Text] [Related]
9. A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia.
Wittmann A; Schlagenhauf F; John T; Guhn A; Rehbein H; Siegmund A; Stoy M; Held D; Schulz I; Fehm L; Fydrich T; Heinz A; Bruhn H; Ströhle A
Eur Arch Psychiatry Clin Neurosci; 2011 Apr; 261(3):185-94. PubMed ID: 21113608
[TBL] [Abstract][Full Text] [Related]
10. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
[TBL] [Abstract][Full Text] [Related]
11. MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.
Reif A; Richter J; Straube B; Höfler M; Lueken U; Gloster AT; Weber H; Domschke K; Fehm L; Ströhle A; Jansen A; Gerlach A; Pyka M; Reinhardt I; Konrad C; Wittmann A; Pfleiderer B; Alpers GW; Pauli P; Lang T; Arolt V; Wittchen HU; Hamm A; Kircher T; Deckert J
Mol Psychiatry; 2014 Jan; 19(1):122-8. PubMed ID: 23319006
[TBL] [Abstract][Full Text] [Related]
12. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia.
Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U
J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445
[TBL] [Abstract][Full Text] [Related]
13. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder.
Lim JA; Lee YI; Jang JH; Choi SH
Medicine (Baltimore); 2018 Sep; 97(38):e12422. PubMed ID: 30235717
[TBL] [Abstract][Full Text] [Related]
14. Fear of Fear and Broad Dimensions of Psychopathology over the Course of Cognitive Behavioural Therapy for Panic Disorder with Agoraphobia in Japan.
Ogawa S; Kondo M; Ino K; Ii T; Imai R; Furukawa TA; Akechi T
East Asian Arch Psychiatry; 2017 Dec; 27(4):150-5. PubMed ID: 29259145
[TBL] [Abstract][Full Text] [Related]
15. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
[TBL] [Abstract][Full Text] [Related]
16. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
[TBL] [Abstract][Full Text] [Related]
17. Effects of Cognitive Behavioral Therapy on Neural Processing of Agoraphobia-Specific Stimuli in Panic Disorder and Agoraphobia.
Wittmann A; Schlagenhauf F; Guhn A; Lueken U; Elle M; Stoy M; Liebscher C; Bermpohl F; Fydrich T; Pfleiderer B; Bruhn H; Gerlach AL; Straube B; Wittchen HU; Arolt V; Heinz A; Kircher T; Ströhle A
Psychother Psychosom; 2018; 87(6):350-365. PubMed ID: 30269148
[TBL] [Abstract][Full Text] [Related]
18. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia.
Lueken U; Straube B; Konrad C; Wittchen HU; Ströhle A; Wittmann A; Pfleiderer B; Uhlmann C; Arolt V; Jansen A; Kircher T
Am J Psychiatry; 2013 Nov; 170(11):1345-55. PubMed ID: 23982225
[TBL] [Abstract][Full Text] [Related]
19. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia.
Swoboda H; Demal U; Krautgartner M; Amering M
J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667
[TBL] [Abstract][Full Text] [Related]
20. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
